Physician profile

Basil Younes

Cardiovascular Disease · Torrance, CA

NPI 1669674933

$27,478.68

in general payments reported to CMS, 2019-2025

48 companies · $13K in 2025

The $13K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$13,669.86
Travel and Lodging$3,342.94
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$2,400.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Penumbra, INC. $8,436.64 2024-2025 Indigo System, Penumbra System
Abiomed $2,487.20 2022-2025 Impella
Novartis Pharmaceuticals Corporation $1,470.33 2019-2025
Abbott Laboratories $1,318.34 2019-2025 Aveir, Confirm Rx, Navitor
Shockwave Medical, INC $1,100.42 2022-2025 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Boston Scientific Corporation $1,093.09 2019-2025 Avvigo Guidance System, Rotapro, Synergy
Merck Sharp & Dohme LLC $953.12 2021-2025 Verquvo, Capvaxive
Medtronic, INC. $948.10 2021-2025 Micra, Epsila Ev, Propel
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $895.13 2019-2025 Lifevest
Astrazeneca Pharmaceuticals LP $751.73 2019-2025 Farxiga, Wainua, Brilinta
Boehringer Ingelheim Pharmaceuticals, INC. $702.19 2021-2025 Jardiance
Pfizer INC. $688.52 2019-2025
Novo Nordisk INC $624.35 2021-2025 Ozempic, Wegovy
Amgen INC. $617.03 2019-2025 Repatha, Repatha
Alnylam Pharmaceuticals INC. $604.95 2022-2025 Amvuttra
Show all 48 companies
CompanyGeneral paymentsYearsTop products
Sanofi-Aventis U.S. LLC $520.57 2019-2022
Kestra Medical Technology Services, INC. $503.54 2022-2025 Assure Wcd
E.R. Squibb & Sons, L.L.C. $439.28 2019-2025 Camzyos, Eliquis
Bayer Healthcare Pharmaceuticals INC. $423.12 2024-2025
Cardiovascular Systems INC. $409.21 2019
Janssen Pharmaceuticals, INC $372.02 2019-2024 Xarelto
Impulse Dynamics (USA) INC. $215.22 2023 Optimizer
Lilly USA, LLC $187.22 2021-2025 Mounjaro, Zepbound
Bridgebio Pharma, INC. $180.94 2025 Attruby
Kiniksa Pharmaceuticals International, Plc $178.72 2024 Arcalyst
Regeneron Healthcare Solutions, INC. $145.57 2019
Scpharmaceuticals INC. $120.67 2023-2025
Bard Peripheral Vascular, INC. $109.45 2021
Venclose INC. $108.40 2020
Amarin Pharma, INC. $106.89 2020-2021
Inari Medical, INC. $104.22 2022-2024 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Biotronik INC. $98.60 2021-2022
Itamar Medical INC $66.31 2023 Watchpatone
Edwards Lifesciences Corporation $64.01 2022-2023 Pascal
Csl Behring $63.32 2021
Stryker Corporation $52.52 2021-2025 Triever20
Kiniksa Pharmaceuticals, LTD. $49.34 2023 Arcalyst
Tactile Systems Technology INC $35.02 2020-2022
Chiesi USA, INC. $29.66 2020
Akcea Therapeutics, INC. $29.24 2019
Philips North America LLC $26.65 2025 Coronary Other
Altathera Pharmaceuticals LLC $26.45 2024 Sotalol Hydrochloride
Baxter Healthcare $23.17 2023 Hillrom - Carnation Ambulatory Monitor
Lantheus Medical Imaging, INC. $22.10 2025
Elutia, INC. $21.85 2022
Teleflex LLC $20.16 2020
Cook Medical LLC $18.09 2024 Zilver Ptx
Lexicon Pharmaceuticals, INC. $16.01 2023 Inpefa

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Basil Younes

$27,478.68

in general payments reported 2019-2025

Years
2019-2025
Top company
Penumbra, INC.
Context
The $13K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/30930/basil-younes

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.